What is Avery Biomedical Devices?
Avery Biomedical Devices operates at the intersection of neurostimulation and respiratory care, primarily recognized for the development of the Avery Diaphragm Pacemaker. This sophisticated phrenic nerve stimulator is engineered to address the needs of patients with high spinal cord injuries, central sleep apnea, and diaphragm paralysis. By facilitating vent-free breathing, the company's fully implantable systems offer a significant improvement in patient mobility and independence compared to traditional mechanical ventilation.
With a legacy spanning over five decades, the company has maintained a rigorous focus on safety and reliability. Its products, which feature dual redundant designs to mitigate the risk of system failure, have secured both FDA approval and CE marking. This regulatory validation allows Avery Biomedical Devices to serve a diverse patient demographic, effectively positioning the firm as a leader in the niche but essential market of long-term respiratory support.
How much funding has Avery Biomedical Devices raised?
Avery Biomedical Devices has raised a total of $423K across 2 funding rounds:
Debt
$150K
Debt
$273K
Debt (2020): $150K with participation from PPP
Debt (2021): $273K led by PPP
Key Investors in Avery Biomedical Devices
PPP
Public-Private Partnership
Undisclosed Investor
An institutional partner providing capital to support the scaling of life-critical medical device manufacturing.
Undisclosed Investor
A strategic backer specializing in long-term healthcare infrastructure and medical innovation financing.
What's next for Avery Biomedical Devices?
Looking ahead, the strategic deployment of the $273K will likely focus on enhancing manufacturing capabilities and broadening the clinical adoption of their pacing systems. Given the company's late-stage lifecycle, the focus is expected to shift toward optimizing supply chain resilience and potentially exploring new indications for their core technology. By maintaining its commitment to high-reliability engineering, Avery Biomedical Devices is well-positioned to sustain its market leadership while addressing the evolving needs of the global healthcare landscape. The firm's ability to integrate its technology into standard clinical workflows will be a key determinant of its future growth and long-term value creation for stakeholders.
See full Avery Biomedical Devices company page
